1. A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer
   Yuhan Sun et al, 2021, Frontiers in Immunology CrossRef
2. Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response
   Nicola E. Annels et al, 2020, Frontiers in Oncology CrossRef
3. BCG in Bladder Cancer Immunotherapy
   Song Jiang et al, 2022, Cancers CrossRef